Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Pharmacotherapy
|
September 1, 1982
Alprazolam: pharmacokinetics, clinical efficacy, and mechanism of action
J A Fawcett, H M Kravitz
The Journal of the American Osteopathic Association
|
September 1, 1984
Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders
H M Kravitz, H C Sabelli, J Fawcett
Depression and Anxiety
|
September 22, 2000
Recovery from a recurrent major depressive episode
H M Kravitz, R W Bloom, J Fawcett
The Journal of Clinical Psychiatry
|
October 1, 1993
Alprazolam and depression: a review of risks and benefits
H M Kravitz, J Fawcett, A J Newman
Psychiatry Research
|
May 1, 1990
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication
H M Kravitz, L Fogg, J Fawcett, et al.
Journal of Affective Disorders
|
October 1, 1990
Challenging the amphetamine challenge test: report of an antidepressant treatment study
H M Kravitz, J H Edwards, J Fawcett, et al.
Psychological Medicine
|
November 25, 2014
Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?
J T Bromberger, L Schott, H M Kravitz, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1987
Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients
J Fawcett, J H Edwards, H M Kravitz, et al.
The Journal of Rheumatology
|
September 1, 1992
Biochemical clues to a fibromyalgia-depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls
H M Kravitz, R Katz, E Kot, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1991
CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression
J Fawcett, H M Kravitz, J M Zajecka, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Pharmacotherapy
|
September 1, 1982
Alprazolam: pharmacokinetics, clinical efficacy, and mechanism of action
J A Fawcett, H M Kravitz
The Journal of the American Osteopathic Association
|
September 1, 1984
Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders
H M Kravitz, H C Sabelli, J Fawcett
Depression and Anxiety
|
September 22, 2000
Recovery from a recurrent major depressive episode
H M Kravitz, R W Bloom, J Fawcett
The Journal of Clinical Psychiatry
|
October 1, 1993
Alprazolam and depression: a review of risks and benefits
H M Kravitz, J Fawcett, A J Newman
Psychiatry Research
|
May 1, 1990
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication
H M Kravitz, L Fogg, J Fawcett, et al.
Journal of Affective Disorders
|
October 1, 1990
Challenging the amphetamine challenge test: report of an antidepressant treatment study
H M Kravitz, J H Edwards, J Fawcett, et al.
Psychological Medicine
|
November 25, 2014
Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?
J T Bromberger, L Schott, H M Kravitz, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1987
Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients
J Fawcett, J H Edwards, H M Kravitz, et al.
The Journal of Rheumatology
|
September 1, 1992
Biochemical clues to a fibromyalgia-depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls
H M Kravitz, R Katz, E Kot, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1991
CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression
J Fawcett, H M Kravitz, J M Zajecka, et al.
Page
of 5